These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer. Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609 [TBL] [Abstract][Full Text] [Related]
3. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107 [TBL] [Abstract][Full Text] [Related]
4. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244 [TBL] [Abstract][Full Text] [Related]
5. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131 [TBL] [Abstract][Full Text] [Related]
6. Association of RNF43 Genetic Alterations With BRAF Vogel A; Murugesan K; Kendre G; Quintanilha JCF; Ross JS; Brummer T; Saborowski A JCO Precis Oncol; 2024 Feb; 8():e2300411. PubMed ID: 38394466 [TBL] [Abstract][Full Text] [Related]
11. RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer. Shang P; Lu J; Song F; Zhao Y; Hong W; He Y; Shen W; Geng L Front Oncol; 2023; 13():1119587. PubMed ID: 37409251 [TBL] [Abstract][Full Text] [Related]
12. RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer. Lai C; Sun W; Wang X; Xu X; Li M; Huang D; Xu E; Lai M; Zhang H Pathol Res Pract; 2019 Aug; 215(8):152453. PubMed ID: 31122752 [TBL] [Abstract][Full Text] [Related]
13. The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways. Bleijenberg AG; IJspeert JE; Mulder JB; Drillenburg P; Stel HV; Lodder EM; Carvalho B; Jansen J; Meijer G; van Eeden S; Dekker E; van Noesel CJ J Pathol; 2022 Jun; 257(2):239-249. PubMed ID: 35143042 [TBL] [Abstract][Full Text] [Related]
14. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis. Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196 [TBL] [Abstract][Full Text] [Related]
15. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers. Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255 [TBL] [Abstract][Full Text] [Related]
16. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis. Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109 [TBL] [Abstract][Full Text] [Related]
17. BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer. Quintanilha JCF; Graf RP; Oxnard GR Oncologist; 2023 Mar; 28(3):e171-e174. PubMed ID: 36779536 [TBL] [Abstract][Full Text] [Related]
18. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers. Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230 [TBL] [Abstract][Full Text] [Related]
19. Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Zlobec I; Kovac M; Erzberger P; Molinari F; Bihl MP; Rufle A; Foerster A; Frattini M; Terracciano L; Heinimann K; Lugli A Int J Cancer; 2010 Dec; 127(11):2569-75. PubMed ID: 20162668 [TBL] [Abstract][Full Text] [Related]
20. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis. Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]